Search
for

    Sort by

    Research 331–360 of 1000+

    1. Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts Uro · 2023 · 2 citations
    2. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    3. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis Asian Journal of Andrology · 2021 · 2 citations
    4. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    5. Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors Indian Journal of Pharmaceutical Education · 2018 · 2 citations
    6. Prescribing to save patients money: Ethical considerations Journal of The American Academy of Dermatology · 2018 · 2 citations
    7. Effects of 5-alpha reductase inhibitors Current Opinion in Urology · 2018 · 2 citations
    8. A human serum‐enriched medium formulation supports high viability and marker expression in primary melanocyte cultures from the outer root sheath and epidermis Experimental Dermatology · 2017 · 2 citations
    9. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    10. Discriminating in favour of or against men with increased risk of finasteride-related side effects? Experimental Dermatology · 2016 · 2 citations
    11. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system DOAJ (DOAJ: Directory of Open Access Journals) · 2016 · 2 citations
    12. Testosterone metabolite nonessential for androgen effects Nature Reviews Endocrinology · 2012 · 2 citations
    13. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    14. 황금(黃芩)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향 The Journal of Internal Korean Medicine · 2009 · 2 citations
    15. Finasteride versus dutasteride: a real-world economic evaluation. PubMed · 2007 · 2 citations
    16. The search for bioactive compounds in tropical plants to target hormone imbalance associated diseases edoc (University of Basel) · 2007 · 2 citations
    17. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    18. Crystal Structure and Synthesis of 17α-Hexanoyloxy-16β-methylpregna-4,6-diene-3,20-dione Analytical Sciences · 2001 · 2 citations
    19. Diseases of the Canine Prostate Gland Veterinary medicine and science · 2022 · 1 citations
    20. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations
    21. Endocrine disruptors as risk factors for idiopathic premature thelarche in girls: A case-control study Archivos Argentinos de Pediatria · 2025 · 1 citations
    22. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    23. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Human Genomics · 2024 · 1 citations
    24. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study Scientific Reports · 2023 · 1 citations
    25. 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study British Journal of Clinical Pharmacology · 2022 · 1 citations
    26. Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines European Journal of Pharmacology · 2022 · 1 citations
    27. Anti-androgenic potential of the fruit extracts of certain Egyptian <i>Sabal</i> species and their genetic variability studies: a metabolomic-molecular modeling approach Food & Function · 2022 · 1 citations
    28. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance British Journal of Clinical Pharmacology · 2021 · 1 citations
    29. A histological study of the effect of panax ginseng versus finasteride on induced benign prostatic hyperplasia in rats with potentiality of spontaneous recovery The Egyptian Journal of Histology · 2020 · 1 citations
    30. Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · 2020 · 1 citations